BioPharma Credit PLC (BPCR.L)

USD 0.89

(0.91%)

Total Debt Summary of BioPharma Credit PLC

  • BioPharma Credit PLC's latest annual total debt in 2023 was - USD , down 0.0% from previous year.
  • BioPharma Credit PLC's latest quarterly total debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • BioPharma Credit PLC reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • BioPharma Credit PLC reported annual total debt of - USD in 2021, down 0.0% from previous year.
  • BioPharma Credit PLC reported quarterly total debt of - USD for 2024 Q1, down 0.0% from previous quarter.
  • BioPharma Credit PLC reported quarterly total debt of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Total Debt Chart of BioPharma Credit PLC (2023 - 2017)

Historical Annual Total Debt of BioPharma Credit PLC (2023 - 2017)

Year Total Debt Total Debt Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Total Debt Comparison of BioPharma Credit PLC

Name Total Debt Total Debt Difference
Ameriprise Financial, Inc. 5.75 Billion USD 100.0%
Gladstone Investment Corporation 398.34 Million USD 100.0%
Principal Financial Group, Inc. 3.93 Billion USD 100.0%
Africa Opportunity Fund Limited - USD NaN%
BH Macro Limited - USD NaN%
CATCo Reinsurance Opportunities Fund Ltd. - USD NaN%
Craven House Capital Plc - USD NaN%
JPEL Private Equity Limited - USD NaN%
Pershing Square Holdings, Ltd. 2.35 Billion USD 100.0%
Ecofin U.S. Renewables Infrastructure Trust PLC - USD NaN%
RTW Venture Fund Limited 1.19 Million USD 100.0%
Tufton Oceanic Assets Limited - USD NaN%
Symphony International Holdings Limited - USD NaN%
Tetragon Financial Group Limited 250 Million USD 100.0%
Taylor Maritime Investments Limited - USD NaN%
TMT Investments PLC - USD NaN%
Third Point Investors Limited - USD NaN%